AMA applauds congressional action on prescription drug transparency

| 1 Min Read

Statement attributable to:
Barbara McAneny, M.D.
President, American Medical Association

“The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward. Patients and their physicians want to be armed with more information, yet the current situation is opaque if not impenetrable. The committee is rightfully determined to expose factors that lead to high drug prices, and we look forward to continuing our efforts in that regard.”

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Man listens on a phone

Physician peer support is vital. Here’s what it should look like.

| 6 Min Read
Smiling healthcare worker with hand on patient's shoulder

Stronger belonging may help ease physician burnout

| 6 Min Read
Health app on a smartphone

Here’s how to make the most of patients’ wearable data

| 6 Min Read
Patient in hospital bed

This superbug's toll exceeds 3,400. How to protect your loved ones.

| 5 Min Read